Intensity Therapeutics (INTS) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order at 10:30 A.M. Eastern Time and held virtually to improve stockholder access.

• Agenda available online, with a Q&A session scheduled at the end.

• Introduction of directors, executive officers, legal counsel, and Inspector of Election.

Board and executive committee updates

• Dr. Emer Leahy and Lewis Bender presented as candidates for re-election to the board.

• Joseph Talamo served as Secretary; John Wesolowski and legal counsel present for questions.

Shareholder proposals

• Election of two directors for terms expiring in 2029.

• Ratification of EisnerAmper LLP as auditors for fiscal year 2026.

• Amendment to 2021 Stock Incentive Plan to increase authorized shares by 150,000.

• Amendment to 2024 Employee Stock Purchase Plan to increase authorized shares by 25,000.

• Approval for potential postponement or adjournment of the meeting to solicit additional proxies if needed.